Floatz logo

Recombinant Vesicular Stomatitis Virus-Expressing Human Interferon Beta And Sodium-Iodide Symporter

Recurrent Adult Acute Myeloid Leukemia

Mayo ClinicvaccinePhase 1Active
CC
43/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
28/ 100
Competitive Position
89/ 100

Competitive context

22 Active assets in the Recurrent Adult Acute Myeloid Leukemia cohort.

Asset / SponsorPhaseRating
Cytosin-Arabinosid
Institute of Hematology & Blood Diseases Hospital, China
Phase 3BBB
(+)-VINCRISTINE
Janssen Research & Development, LLC
Phase 3BBB
ETOPOSIDE
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University
Phase 3BBB
FLUTICASONE
Virginia Commonwealth University
Phase 2BBB
Mitoxantrone
Medical College of Wisconsin
Phase 2BBB

View all 50 →

Same molecule, other indications

Recombinant Vesicular Stomatitis Virus-Expressing Human Interferon Beta And Sodium-Iodide Symporter is also rated in:

Advanced Clear Cell Renal Cell CarcinomaDormant
CCC
Indicative ·
53 / 100
View asset →
Stage III Renal Cell Cancer AJCC v8Dormant
CCC
Indicative ·
53 / 100
View asset →
Recurrent Angioimmunoblastic T-Cell LymphomaDormant
CC
Indicative ·
43 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →